skip to Main Content

At IRBM we’ll apply our expertise and state-of-the-art assays and technologies across the spectrum of discovery and translational biology to understand disease mechanisms, to help to progress your drug discovery program.

We develop the most biologically relevant assays, ranging from specific target selection to cell interrogation and functional assessment. We can use primary cells or stem cells, and in vivo studies on murine and rodent animal models, following transcriptional profiling and circulating biomarkers, together with efficacy endpoints.

Our suite of state-of-the art assays allow us to efficiently integrate biology, pharmacokinetics and drug metabolism. This integrated approach enables us to identify key molecular interactions and networks related to the target of interest.

Find out more about our comprehensive suite of assays and screening technologies:

BIOCHEMICAL
AND CELL-BASED
ASSAYS

ASSAY
DEVELOPMENT

HIGH
THROUGHPUT
SCREENING

HIGH
CONTENT
SCREENING

BIOPHYSICAL
APPROACHES

STRUCTURAL
BIOLOGY

PROTEIN
PRODUCTION

Back To Top